✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Themis Medicare Ltd.

THEMISMED

Market Cap
₹1,286 Cr.
P/E
27.88

Themis Medicare Ltd.

  • Themis Medicare
  • Shree Ganesh Remed.
  • Hester Biosciences
  • TJI Pharma - Small Cap
FAQs on Themis Medicare Ltd. Shareprice

Themis Medicare has given lower returns compared to its competitors.
Themis Medicare has grown at ~14.07% over the last 7yrs while peers have grown at a median rate of 17.7%

Yes, Themis Medicare is expensive.
Latest PE of Themis Medicare is 27.46, while 3 year average PE is 24.85.
Also latest EV/EBITDA of Themis Medicare is 20.75 while 3yr average is 20.68.

View FAQ's On Business
Growth Table
  • Themis Medicare Ltd.
  • Shree Ganesh Remed.
  • Hester Biosciences
Balance Sheet
  • Themis Medicare Ltd.
  • Shree Ganesh Remed.
  • Hester Biosciences
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Themis Medicare Ltd.
  • Shree Ganesh Remed.
  • Hester Biosciences
Cash Flow
  • Themis Medicare Ltd.
  • Shree Ganesh Remed.
  • Hester Biosciences
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Themis Medicare Ltd.
  • Shree Ganesh Remed.
  • Hester Biosciences
Quarterly Results
  • Themis Medicare Ltd.
  • Shree Ganesh Remed.
  • Hester Biosciences
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Themis Medicare Ltd. Financials

Balance sheet of Themis Medicare is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of Themis Medicare is increasing.
Latest debt of Themis Medicare is ₹63.85 Crs as of Sep-24.
This is greater than Mar-24 when it was ₹57.23 Crs.

No, profit is decreasing.
The profit of Themis Medicare is ₹34.73 Crs for TTM, ₹43.52 Crs for Mar 2024 and ₹56.9 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Themis Medicare latest dividend payout ratio is 10.57% and 3yr average dividend payout ratio is 8.32%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech